From Workforce Diversity to Key Cultural Competency Strategies to End Racial Disparities in Opioid Treatment Outcomes Across the Nation

从劳动力多元化到关键文化能力战略，以消除全国阿片类药物治疗结果的种族差异

• 批准号: 10056327
• 负责人: Erick Guerrero
• 金额: $ 46.75万
• 依托单位: TEXAS A&M UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-12-01 至 2025-11-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10056327
• 关键词: Address; Affect; African American; Aftercare; Buprenorphine; Characteristics; Client; Data; Data Set; Decision Making; Dependence; Dose; Drug abuse; Gold; Health Personnel; Health Services Accessibility; Hispanics; Improve Access; Knowledge; Linguistics; Link; Maintenance; Measurement; Measures; Medicaid; Methadone; Minority; Minority Groups; Modeling; Naltrexone; Opioid; Patients; Pharmaceutical Preparations; Policy Maker; Process; Process Measure; Professional counselor; Property; Psychometrics; Public Health; Quality of Care; Race; Recording of previous events; Recovery; Research; Resources; Respondent; Role; Sampling; Services; Source; Substance Use Disorder; Surveys; System; Testing; Treatment outcome; Variant; Wait Time; Woman; Work; cultural competence; disparity elimination; disparity reduction; dosage; ethnic diversity; ethnic minority population; evidence base; health disparity; improved; instrument; medication-assisted treatment; minority health; opioid epidemic; opioid treatment program; opioid use disorder; payment; programs; racial and ethnic; racial and ethnic disparities; racial disparity; racial diversity; racial minority; response; social culture; standard measure; substance use treatment; treatment disparity; treatment program

PROJECT SUMMARY/ABSTRACT In response to PAR-18-747, Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01), this study seeks to determine the role of culturally competent strategies, and in particular workforce diversity, to improve treatment access, engagement, and medication- assisted treatment (MAT) maintenance dosage, i.e., methadone, buprenorphine and naltrexone for African- American and Hispanic populations in opioid treatment programs (OTP) nationwide. The study will rely on the National Drug Abuse Treatment System Survey (NDATSS), which is a unique, nationally representative longitudinal data (2005-2017); the study also will collect two waves of new data in 2021 and 2023 to assess the effect of culturally and linguistically appropriate services (CLAS) on OTP process measures [wait time, retention, and adequate MAT dosages). The study seeks to improve measurement of cultural competence using a gold standard instrument - the Cultural Competency Organizational Assessment (COA360 [CLAS]) and assess its predictive validity on process measures in 2021 and 2023. Findings will inform treatment programs’ use of cultural competency strategies to improve OTP wait time, retention and adequate dosage, and with these efforts reduce racial/ethnic disparities in opioid use disorder treatment. Policy-makers will be able to make decisions about how to allocate scarce resources needed to address the opioid epidemic.

项目摘要/摘要 响应PAR-18-747，应对阿片类药物流行在少数民族健康和健康中的挑战 美国的差异研究(R01)，这项研究试图确定文化能力的作用 战略，特别是劳动力多样化，以改善治疗机会、参与度和药物治疗- 辅助治疗(MAT)维持剂量，即用于非洲的美沙酮、丁丙诺啡和纳曲酮- 美国和西班牙裔人口参加全国阿片类药物治疗计划(OTP)。这项研究将依靠 国家药物滥用治疗系统调查(NDATSS)，这是一个独特的、具有全国代表性的 纵向数据(2005-2017)；该研究还将收集2021年和2023年的两波新数据，以评估 文化和语言上适当的服务(CLAS)对动态口令流程措施的影响[等待时间， 保留率和足够的垫片剂量)。这项研究旨在改进文化能力的测量 使用黄金标准工具-文化能力组织评估(COA360[Clas])和 评估其对2021年和2023年流程措施的预测有效性。研究结果将为治疗计划提供信息 使用文化能力战略，以改善口服避孕药的等待时间、滞留和充足的剂量，并 这些努力减少了阿片类药物使用障碍治疗方面的种族/族裔差异。政策制定者将能够 就如何分配应对阿片类药物流行所需的稀缺资源作出决定。